The Food and Drug Administration USA (FDA) authorized updated vaccines against against the new variants of Covid-19 that circulate in almost all countries, most of them omicron, which are intended to reduce hospitalizations and deaths.
In a statement, the FDA indicates that the approved vaccines They are mRNA updated for 2023-2024 and are manufactured by Moderna and Pfizer. In accordance with the totality of the evidence and the contributions of the expert advisors of the FDAthese vaccines have been updated to include a monovalent (single) component that corresponds to the XBB.1.5 omicron variant.
According to the FDApeople over five years of age will be able to receive a dose of the updated vaccine at least two months after the last dose of any vaccine against Covid-19.
“Vaccination remains critical for public health and continued protection against the serious consequences of Covid-19, including hospitalization and death,” said Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research.
“The public can be assured that these updated vaccines have met the agency’s rigorous scientific standards for safety, efficacy and manufacturing quality. We highly encourage those who are eligible to consider getting vaccinated,” he added.
US reports rise in cases of an omicron subtype
The authorization of the FDA It is known after a surge in cases in late summer, at a time when the new EG.5 subvariant of omicron – nicknamed “eris” – has begun to spread rapidly in USA and in other parts of the world.
Advisors to the US Centers for Disease Control and Prevention (CDC) are scheduled to meet on Tuesday, September 12, to recommend who should receive the vaccine.
Approval from CDC Director Mandy Cohen, expected soon, should clear the way for the new vaccines. Cohen has stated that she hopes vaccines will be rolled out in September.
2023-09-11 22:23:11
#FDA #approves #updated #vaccines #Covid19 #United #States
